Toxic multinodular goiter: Difference between revisions
Usama Talib (talk | contribs) |
Usama Talib (talk | contribs) |
||
Line 31: | Line 31: | ||
==Treatment== | ==Treatment== | ||
[[Toxic | [[Toxic multinodular goiter medical therapy|Medical Therapy]] | [[Toxic multinodular goiter surgery|Surgery]] | [[Toxic multinodular goiter primary prevention|Primary Prevention]] | [[Toxic multinodular goiter secondary prevention|Secondary Prevention]] | [[Toxic multinodular goiter cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Toxic multinodular goiter future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== |
Revision as of 17:22, 7 August 2017
Toxic multinodular goiter Microchapters |
Differentiating Toxic multinodular goiter from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Toxic multinodular goiter On the Web |
American Roentgen Ray Society Images of Toxic multinodular goiter |
Risk calculators and risk factors for Toxic multinodular goiter |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Synonyms and keywords:
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Toxic multinodular goiter from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X-Ray Findings | CT-Scan Findings | MRI Findings | Other Diagnostic Studies | Other Imaging Findings
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies